Product Information
GENTEAL TEARS 0.1%-0.3% DROP is a brand product labeled by Alcon Laboratories, Inc., priced at $0.2997 per EA under NDC 00065806301. Its NADAC has been published 342 times since Mar 18, 2020.
Strength
1; 3 mg/mL; mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
00065806301
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DEXTRAN 70; HYPROMELLOSE 2910 (4000 MPA.S)Approval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
7/3/2018
Pharmacological Classes
Price Statistics
The NADAC for GENTEAL TEARS 0.1%-0.3% DROP has been published 342 times since Mar 18, 2020, and over the history we have for it it has risen 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2997 per EA |
|---|---|
| All-time high | $0.3129 (Apr 12, 2023) |
| All-time low | $0.2592 (Apr 21, 2021) |
| 52-week high | $0.3000 |
| 52-week low | $0.2974 |
| Median price | $0.2912 |
| Average price | $0.2878 |
| Largest weekly change | +10.7% (Jun 23, 2021) |
| Weeks tracked | 342 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextran 70, hypromellose 2910 market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alcon Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextran 70, hypromellose 2910 market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Plasma Volume Expander class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GENTEAL TEARS 0.1%-0.3% DROP?
The current National Average Drug Acquisition Cost (NADAC) for GENTEAL TEARS 0.1%-0.3% DROP, manufactured by Alcon Laboratories, Inc., is $0.2997 per EA (NDC 00065806301), effective Sep 30, 2026.
How has the price of GENTEAL TEARS 0.1%-0.3% DROP changed over time?
Over the history we have for it, the NADAC for GENTEAL TEARS 0.1%-0.3% DROP has risen 11.4%. It has been tracked across 342 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for GENTEAL TEARS 0.1%-0.3% DROP?
Since Mar 18, 2020, the NADAC for GENTEAL TEARS 0.1%-0.3% DROP has ranged from a low of $0.2592 (Apr 21, 2021) to a high of $0.3129 (Apr 12, 2023), with a median of $0.2912 per EA.
Are there cheaper alternatives to GENTEAL TEARS 0.1%-0.3% DROP?
No other NADAC-published product currently shares the active ingredient and strength of GENTEAL TEARS 0.1%-0.3% DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GENTEAL TEARS 0.1%-0.3% DROP?
GENTEAL TEARS 0.1%-0.3% DROP (NDC 00065806301) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.